Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera

Journal of Proteome Research

Volumn 12, Issue 5, 2013, Pages 2260-2268

  Nicolardi, Simone ^a   Van Der Burgt, Yuri E M ^a   Dragan, Irina ^a   Hensbergen, Paul J ^a   Deelder, André M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

apolipoprotein CIII; fucosylation; glycosylation; HR AM; MALDI FTICR; serum protein profiling; top down proteomics

Indexed keywords

APOLIPOPROTEIN C3; GLYCAN; GLYCOPROTEIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FOURIER TRANSFORM ION CYCLOTRON RESONANCE; FUCOSYLATION; GLYCOSYLATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; APOLIPOPROTEIN C-III; BLOOD PROTEINS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; FOURIER ANALYSIS; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84877122321     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400136p     Document Type: Article

References (37)

1. Jong, M. C.; Hofker, M. H.; Havekes, L. M. Role of ApoCs in lipoprotein metabolism-Functional differences between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol. 1999, 19 (3) 472-484
2. Mauger, J.-F.; Couture, P.; Bergeron, N.; Lamarche, B. Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism J. Lipid Res. 2006, 47 (6) 1212-1218
3. Wang, C. S.; McConathy, W. J.; Kloer, H. U.; Alaupovic, P. Modulation of lipoprotein-lipase activity by apolipoproteins-Effect of apolipoprotein-C-III J. Clin. Invest. 1985, 75 (2) 384-390
4. Batal, R.; Tremblay, M.; Barrett, P. H. R.; Jacques, H.; Fredenrich, A.; Mamer, O.; Davignon, J.; Cohn, J. S. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects J. Lipid Res. 2000, 41 (5) 706-718
5. Onat, A.; Hergenc, G.; Sansoy, V.; Fobker, M.; Ceyhan, K.; Toprak, S.; Assmann, G. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders Atherosclerosis 2003, 168 (1) 81-89
6. Kawakami, A.; Yoshida, M. Apolipoprotein CIII links dyslipidemia with atherosclerosis J. Atheroscler. Thromb. 2009, 16 (1) 6-11
7. Juntti-Berggren, L.; Refai, E.; Appelskog, I.; Andersson, M.; Imreh, G.; Dekki, N.; Uhles, S.; Yu, L.; Griffiths, W. J.; Zaitsev, S.; Leibiger, I.; Yang, S. N.; Olivecrona, G.; Jörnvall, H.; Berggren, P. O. Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (27) 10090-10094
8. Allard, L.; Lescuyer, P.; Burgess, J.; Leung, K.-Y.; Ward, M.; Walter, N.; Burkhard, P. R.; Corthals, G.; Hochstrasser, D. F.; Sanchez, J.-C. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke Proteomics 2004, 4 (8) 2242-2251
9. Cohen, M.; Yossef, R.; Erez, T.; Kugel, A.; Welt, M.; Karpasas, M. M.; Bones, J.; Rudd, P. M.; Taieb, J.; Boissin, H.; Harats, D.; Noy, K.; Tekoah, Y.; Lichtenstein, R. G.; Rubin, E.; Porgador, A. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays PLoS ONE 2011, 6 (1) e14540
10. Vaith, P.; Assmann, G.; Uhlenbruck, G. Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins BBA-Gen. Subjects 1978, 541 (2) 234-240
11. Brewer, H. B.; Shulman, R.; Herbert, P.; Ronan, R.; Wehrly, K. The complete amino acid sequence of alanine apolipoprotein (apoC-III), an apolipoprotein from human plasma very low density lipoproteins J. Biol. Chem. 1974, 249 (15) 4975-4984
12. Wopereis, S.; Grünewald, S.; Morava, é.; Penzien, J. M.; Briones, P.; García-Silva, M. T.; Demacker, P. N. M.; Huijben, K. M. L. C.; Wevers, R. A. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis Clin. Chem. 2003, 49 (11) 1839-1845
13. Wopereis, S.; Grünewald, S.; Huijben, K. M. L. C.; Morava, é.; Mollicone, R.; van Engelen, B. G. M.; Lefeber, D. J.; Wevers, R. A. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects Clin. Chem. 2006, 53 (2) 180-187
14. Sprecher, D. L.; Taam, L.; Brewer, H. B. Two-dimensional electrophoresis of human-plasma apolipoproteins Clin. Chem. 1984, 30 (12) 2084-2092
15. Bruneel, A.; Morelle, W.; Carre, Y.; Habarou, F.; Dupont, D.; Hesbert, A.; Durand, G.; Michalski, J. C.; Drouin-Garraud, V.; Seta, N. Two-dimensional gel electrophoresis of apolipoprotein C-III and other serum glycoproteins for the combined screening of human congenital disorders of O- and N-glycosylation Proteomics Clin. Appl. 2007, 1 (3) 321-324
16. Hancock, W. S.; Bishop, C. A.; Gotto, A. M.; Harding, D. R. K.; Lamplugh, S. M.; Sparrow, J. T. Separation of the apoprotein components of human very low-density lipoproteins by ion-paired, reversed-phase high-performance liquid-chromatography Lipids 1981, 16 (4) 250-259
17. Mazur, M. T.; Cardasis, H. L.; Spellman, D. S.; Liaw, A.; Yates, N. A.; Hendrickson, R. C. Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (17) 7728-7733
18. Wada, Y.; Kadoya, M.; Okamoto, N. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation, and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient Glycobiology 2012, 22 (8) 1140-1144
19. Zhang, Y.; Sinaiko, A.; Nelsestuen, G. Glycoproteins and Glycosylation: Apolipoprotein C3 Glycoforms by Top-Down MALDI-TOF Mass Spectrometry. In Liver Proteomics in Methods in Molecular Biology, 909 ed.; Humana Press: Totowa, NJ, 2012; pp 141-150.
20. Haase, R.; Menke-Möllers, I.; Oette, K. Analysis of human apolipoproteins-C by isoelectric-focusing in immobilized pH gradients Electrophoresis 1988, 9 (9) 569-575
21. Madian, A. G.; Regnier, F. E. Profiling carbonylated proteins in human plasma J. Proteome Res. 2010, 9 (3) 1330-1343
22. Bondarenko, P. V.; Cockrill, S. L.; Watkins, L. K.; Cruzado, I. D.; Macfarlane, R. D. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein J. Lipid Res. 1999, 40 (3) 543-555
23. Nelsestuen, G. L.; Zhang, Y.; Martinez, M. B.; Key, N. S.; Jilma, B.; Verneris, M.; Sinaiko, A.; Kasthuri, R. S. Plasma protein profiling: Unique and stable features of individuals Proteomics 2005, 5 (15) 4012-4024
24. Balog, C. I. A.; Mayboroda, O. A.; Wuhrer, M.; Hokke, C. H.; Deelder, A. M.; Hensbergen, P. J. Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from schistosoma mansoni-infected individuals Mol. Cell. Proteomics 2010, 9 (4) 667-681
25. Nicolardi, S.; van der Burgt, Y. E. M.; Wuhrer, M.; Deelder, A. M. Mapping O-glycosylation of apolipoprotein C-III in MALDI-FTICR protein profiles Proteomics 2013, 13 (6) 992-1001
26. Nicolardi, S.; Palmblad, M.; Dalebout, H.; Bladergroen, M.; Tollenaar, R. A. E. M.; Deelder, A. M.; van der Burgt, Y. E. M. Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling J. Am. Soc. Mass Spectrom. 2010, 21 (9) 1515-1525
27. Bladergroen, M. R.; Derks, R. J. E.; Nicolardi, S.; de Visser, B.; van Berloo, S.; van der Burgt, Y. E. M.; Deelder, A. M. Standardized and automated solid-phase extraction procedures for high-throughput proteomics of body fluids J. Proteomics 2012, 77, 144-153
28. Nicolardi, S.; Dalebout, H.; Bladergroen, M. R.; Mesker, W. E.; Tollenaar, R. A. E. M.; Deelder, A. M.; van der Burgt, Y. E. M. Identification of human serum peptides in Fourier transform ion cyclotron resonance precision profiles Int. J. Proteomics 2012, 804036
29. He, F.; Emmett, M. R.; HaÌŠkansson, K.; Hendrickson, C. L.; Marshall, A. G. Theoretical and experimental prospects for protein identification based solely on accurate mass measurement J. Proteome Res. 2003, 3 (1) 61-67
30. Wuhrer, M.; Deelder, A. M.; van der Burgt, Y. E. M. Mass spectrometric glycan rearrangements Mass Spectrom. Rev. 2011, 30 (4) 664-680
31. Morrisett, J. D.; Jackson, R. L.; Gotto, A. M. Lipoproteins: structure and function Annu. Rev. Biochem. 1975, 44 (1) 183-207
32. Wu, S.; Tao, N.; German, J. B.; Grimm, R.; Lebrilla, C. B. Development of an annotated library of neutral human milk oligosaccharides J. Proteome Res. 2010, 9 (8) 4138-4151
33. Wuhrer, M.; Catalina, M. I.; Deelder, A. M.; Hokke, C. H. Glycoproteomics based on tandem mass spectrometry of glycopeptides J. Chromatogr. B 2007, 849, 115-128
34. Thaysen-Andersen, M.; Wilkinson, B. L.; Payne, R. J.; Packer, N. H. Site-specific characterisation of densely O-glycosylated mucin-type peptides using electron transfer dissociation ESI-MS/MS Electrophoresis 2011, 32 (24) 3536-3545
35. Roghani, A.; Zannis, V. I. Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding J. Biol. Chem. 1988, 263 (34) 17925-17932
36. Maeda, H.; Hashimoto, R. K.; Ogura, T.; Hiraga, S.; Uzawa, H. Molecular cloning of a human apoC-III variant: Thr 74→Ala 74 mutation prevents O-glycosylation J. Lipid Res. 1987, 28 (12) 1405-1409
37. Holleboom, A.; Karlsson, H.; Lin, R. S.; Beres, T.; Sierts, J.; Herman, D.; Stroes, E.; Aerts, J.; Kastelein, J.; Motazacker, M.; Dallinga-Thie, G.; Levels, J.; Zwinderman, A.; Seidman, J.; Seidman, C.; Ljunggren, S.; Lefeber, D.; Morava, E.; Wevers, R.; Fritz, T.; Tabak, L.; Lindahl, M.; Hovingh, G.; Kuivenhoven, J. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man Cell Metabolism 2011, 14 (6) 811-818